Noticias de Haisco Pharmaceutical Group

002653 · SZSE · CNY

62,18 ¥+0,40 %+0,25 ¥

Cierre · 30 de septiembre de 2026

Últimas noticias

Titulares en el idioma original de la fuente.

Lilly’s latest China drug deal; Immunovant’s setback in lupus (se abre en una pestaña nueva)
24 sept 2026
AirNexis Therapeutics Announces that AN01, a Dual PDE3/4 Inhibitor Dry Powder Inhaler (DPI) Met its Primary Endpoint in a Phase 2b COPD Study (HSK39004-T1-202) Conducted in China by AirNexis' partner Haisco Pharmaceutical Group (se abre en una pestaña nueva)
GlobeNewswire · 8 sept 2026
Haisco enters into Exclusive License Agreement with new US venture founded by Population Health Partners and ARCH Venture Partners (se abre en una pestaña nueva)
PR Newswire · 25 ago 2026
Nuvectis Stock Surges Around 97% in 3 Months: Here's Why (se abre en una pestaña nueva)
Zacks · 19 ago 2026
Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights (se abre en una pestaña nueva)
4 ago 2026
StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data (se abre en una pestaña nueva)
TMX Newsfile · 14 jul 2026
Haisco and Nuvectis sign licensing deal for two drugs (se abre en una pestaña nueva)
Hospital Management · 24 jun 2026
Haisco Enters into Exclusive License Agreement with Nuvectis for Two Drug Candidates in Oncology and Complement Indications (se abre en una pestaña nueva)
23 jun 2026
Nuvectis Expands Pipeline with Haisco Licensing Agreement for Two Clinical-Stage Drug Candidates (NVCT) (se abre en una pestaña nueva)
InvestorsHub · 22 jun 2026
Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds (se abre en una pestaña nueva)
GlobeNewswire · 22 jun 2026
Eli Lilly Expands Beyond Obesity With US$4b Vaccine And Genetic Bets (se abre en una pestaña nueva)
Simply Wall St. · 7 jun 2026
Eli Lilly Broadens Beyond Obesity Drugs With Vaccine And Genetic Bets (se abre en una pestaña nueva)
Simply Wall St. · 6 jun 2026
Eli Lilly Deepens Innovation Push Through New Biopharma Collaborations (se abre en una pestaña nueva)
3 jun 2026
Haisco Announces Licensing and Research Collaboration Agreement with Lilly to Develop Innovative Medicines Across Multiple Therapeutic Areas (se abre en una pestaña nueva)
PR Newswire · 1 jun 2026
AbbVie Inc. (ABBV) Inks Licensing Agreement for Pain Medicines Development (se abre en una pestaña nueva)
Insider Monkey · 22 abr 2026
Haisco Grants Global Rights of Innovative Drug HSK39004 to AirNexis in Deal Exceeding USD 1 Billion (se abre en una pestaña nueva)
12 ene 2026